The Five-Year Plan aims to improve China’s rules for buying medicines and medical consumables in bulk

The Five-Year Plan aims to improve China’s rules for buying medicines and medical consumables in bulk

China’s 15th Five-Year Plan (2026–2030) emphasizes reforms to its bulk procurement system for medicines and medical consumables, aiming to enhance efficiency, affordability, and innovation in healthcare. The plan aligns with recent policy shifts that move beyond price-centric procurement models to prioritize value-based purchasing, quality assurance, and supply chain stability. This approach reflects broader goals of industrial modernization and technological self-reliance, as outlined in the plan's focus on upgrading traditional sectors and fostering emerging industries.

Recent rounds of centralized bulk purchases, such as those for surgical devices and medical supplies, have demonstrated the government’s commitment to reducing costs for healthcare providers and patients while encouraging domestic manufacturers to meet higher quality and innovation standards. According to reports, these purchases have also shown the government's intent to address supply chain vulnerabilities and ensure equitable access to essential medical products, particularly in rural and underserved areas.

The 15th Five-Year Plan integrates these procurement strategies with broader economic priorities, including expanding domestic demand and strengthening social welfare systems. By streamlining procurement processes and promoting competition among suppliers, the government aims to balance cost containment with incentives for innovation, supporting both public health outcomes and the growth of China’s medical technology sector.

For foreign businesses, these reforms signal opportunities in collaboration with Chinese firms on advanced medical technologies and supply chain integration, though intensified domestic competition and regulatory scrutiny remain key challenges. The formal implementation of these policies in 2026 will likely shape market dynamics, influencing investment flows and strategic partnerships in the healthcare sector.